Home Cart 0 Sign in  
X

[ CAS No. 66582-32-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 66582-32-9
Chemical Structure| 66582-32-9
Chemical Structure| 66582-32-9
Structure of 66582-32-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 66582-32-9 ]

Related Doc. of [ 66582-32-9 ]

Alternatived Products of [ 66582-32-9 ]

Product Details of [ 66582-32-9 ]

CAS No. :66582-32-9 MDL No. :MFCD00233351
Formula : C12H18O2 Boiling Point : -
Linear Structure Formula :- InChI Key :SGGGHAPHBMPBBV-UHFFFAOYSA-N
M.W : 194.27 Pubchem ID :11127143
Synonyms :

Calculated chemistry of [ 66582-32-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.5
Num. rotatable bonds : 5
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 57.43
TPSA : 29.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.54
Log Po/w (XLOGP3) : 2.08
Log Po/w (WLOGP) : 2.07
Log Po/w (MLOGP) : 2.14
Log Po/w (SILICOS-IT) : 2.65
Consensus Log Po/w : 2.29

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.34
Solubility : 0.884 mg/ml ; 0.00455 mol/l
Class : Soluble
Log S (Ali) : -2.33
Solubility : 0.912 mg/ml ; 0.0047 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.6
Solubility : 0.0485 mg/ml ; 0.000249 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 66582-32-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 66582-32-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 66582-32-9 ]
  • Downstream synthetic route of [ 66582-32-9 ]

[ 66582-32-9 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 100-39-0 ]
  • [ 126-30-7 ]
  • [ 66582-32-9 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 0.0833333 h;
Stage #2: With tetra-(n-butyl)ammonium iodide In tetrahydrofuran; mineral oil at 20℃;
Example 137C
3-(benzyloxy)-2,2-dimethylpropan-1-ol
A solution of 2,2-dimethylpropane-1,3-diol (2 g, 19.20 mmol) in THF (30 mL) was treated with 60percent sodium hydride (0.256 g, 6.40 mmol) at room temperature, and the mixture stirred at room temperature for 5 minutes.
Benzyl bromide (0.761 mL, 6.40 mmol) and tetrabutylammonium iodide (0.709 g, 1.920 mmol) were then added, and the reaction stirred overnight at room temperature.
After this time, the mixture was diluted with ethyl acetate (150 mL) and water (50 mL), and the phases were separated.
The aqueous layer was extracted with ethyl acetate (2*50 mL).
The combined organics were washed with water (2*50 mL) and brine (50 mL) sequentially, dried over Na2SO4, filtered, and concentrated in vacuo.
The residue was purified on silica gel chromatography (10 to 50percent ethyl acetate-heptanes, eluent) to afford the title compound (0.992 g, 80percent).
1H NMR (400 MHz, CDCl3) δ 7.41-7.32 (m, 5H), 4.51 (s, 2H), 3.46 (d, J=5.7 Hz, 2H), 3.33 (s, 2H), 2.55 (t, J=5.9 Hz, 1H), 0.93 (s, 6H). MS (DCI+) m/z 195.0 (M+H).
77% With tetra-(n-butyl)ammonium iodide In toluene at 0 - 20℃; for 16 h; Into a 10-L 4-neck round-bottom flask, was placed 2,2-dimethylpropane-1,3-diol (200 g, 1920 mmol), toluene (1 L), 50percent KOH (aq. solution, 1L), n-Bu4NI (36 g, 97 mmol). Then (bromomethyl)benzene (328 g, 1920 mmol, 1.00 equiv.) was added at 0 °C. The resulting solution was stirred at room temperature for 16 h. The reaction was then quenched by the addition of 1 L of ice-water. The resulting solution was extracted with 2x4 L of ethyl acetate. The combined organic layer was washed with 2x4 L of brine, dried over anhydrous sodium sulfate and concentrated under vacuum. The crude product was purified by silica gel column chromatography to afford the title compound as light yellow oil (77percent). LCMS:mlz=195.0 [M+1]. ‘H-NMR (300 MHz, CDC13) ö: 7.37-7.25 (m, 5H), 4.47 (m, 3H), 3.18 (d, 1=6.4Hz, 4H), 0.82 (s, 6H).
64%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.75 h; Inert atmosphere
Stage #2: at 0 - 20℃; Inert atmosphere
General procedure: The diol (48 mmol, 1 eq) wasdissolved into DMF (120 mL) under argon. At 0°C NaH (1.1 eq, 60percent in mineral oil) was added inone portion and the mixture was stirred at 0°C during 45 min. BnBr (0.97 eq) was added dropwise,the mixture was allowed to warm at room temperature and stirred overnight. The reaction wasquenched with saturated NH4Cl solution (20 mL) and then diluted with water. The crude mixturewas extracted with Et2O and the organic layer was washed with brine, dried over anhydrous MgSO4,filtered and concentrated in vacuo. Benzylated compound was then purified by flashchromatography on silica gel.
62%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 1 h;
Stage #2: at 0 - 20℃;
Step A:
3-Phenylmethoxy-neopentylol (31a)
Adapting a procedure or a variation thereof according to Effenberger, et al., Tetrahedron:
Asymmetry 1995, 6, 271-282, a 1000 mL round-bottomed flask equipped with a magnetic stirring bar and a rubber septum was charged under a nitrogen atmosphere with 2.40 g of a 60 wt-percent suspension of sodium hydride (NaH) in mineral oil (1.44 g, 60.0 mmol).
The hydride was suspended in 50 mL of hexane and the supernatant was decanted, and the residue was dried under reduced pressure. Six-hundred (600) mL of anhydrous tetrahydrofuran (THF) were added under a nitrogen atmosphere and the suspension was cooled to ca. 0° C. (ice bath).
6.24 g (60 mmol) of commercially available neopentyl glycol (2,2-dimethyl-1,3-propandiol) was added and the reaction mixture was stirred for one hour at this temperature until the hydrogen evolution subsided. 5.9 mL of benzyl bromide (8.5 g, 50.0 mmol) was added to the stirred reaction mixture.
The reaction mixture was stirred overnight with gradual warming to room temperature and the solvent was then partially removed under reduced pressure using a rotary evaporator.
The reaction was quenched by addition of a one normal (1 N) aqueous solution of hydrogen chloride (HCl) and the product was extracted with ethyl acetate.
The combined organic extracts were washed with water and brine, dried over anhydrous magnesium sulfate (MgSO4), filtered, and the solvents were removed under reduced pressure using a rotary evaporator.
The residue was purified by silica gel chromatography using a mixture of ethyl acetate (EtOAc) and hexane (Hxn) as eluent (EtOAc/Hxn=1:4) to provide 6.0 g (62percent yield) of the title compound (31a) as a colorless liquid. Rf=0.34 (EtOAc/Hxn=1:4).
1H NMR (400 MHz, CDCl3): δ=0.953 (s, 6H), 2.62 (br. t, J=5.6 Hz, 1H), 3.34 (s, 2H), 3.47 (d, J=5.6 Hz, 2H), 4.54 (s, 2H), 7.27-7.38 (m, 5H) ppm. MS (ESI) m/z 195.10 (M+H)+, 217.10 (M+Na)+.
The analytical data was consistent with the data given in the literature.
62% With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 12 h; [00319] Into a 250-mL round-bottom flask, was placed 2,2-dimethylpropane-1,3-diol (10.4 g, 99.86 mmol) and N,N-dimethylformamide (100 mL). This was followed by the addition of 60percent sodium hydride (4 g, 100.00 mmol), in portions at 0°C. To this was added (bromomethyl)benzene (13.68 g, 79.98 mmol) at 0°C. The resulting solution was stuffed for 12 h at room temperature and then diluted with 200 mL of NH4C1 (sat. aq). The resulting solution was extracted with 2x200 mL of ethyl acetate and the organic layers were combined and dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was purified by silica gel column with ethyl acetate/petroleum ether (1:10) to obtain 12 g (62percent) of 3-(benzyloxy)-2,2-dimethylpropan-1-ol as light yellow oil. ‘H NMR (300 MHz, DMSOd 6): 7.43-7.24 (m, 5H), 4.51-4.41 (m, 3H), 3.25-3.15 (m, 4H), 0.84 (s, 6H) ppm.
58%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5 h; Inert atmosphere
Stage #2: at 20℃;
[00509] 2,2-Dimethylpropane-l,3-diol 159 (4.24 g, 40 mmol) was dissolved in 120 mL of THF. To this mixture, was added NaH (1.92 g, 48 mmol, 60percent in mineral oil) at 0 °C under nitrogen atmosphere. After stirring at 0 °C for 30 min, benzyl bromide (6.84 g, 40 mmol) was added to this mixture, and the resulting mixture was stirred at room temperature overnight. The reaction mixture was then transferred into iced water and extracted with ethyl acetate (50 mL X 3). The combined organic layers were washed with brine, dried over anhydrous Na2S04, and concentrated under reduced pressure to obtain crude product, which was purified by silica gel chromatography (10percent ethyl acetate/petroleum ether) to give 4.5 g 3- (benzyloxy)-2,2-dimethylpropan-l-ol 160 (58percent yield). LCMS: m/z 195.1 [M+H]+, fR = 1.70 min.
51%
Stage #1: With potassium <i>tert</i>-butylate In 1,4-dioxane at 0 - 20℃; for 1 h; Inert atmosphere
Stage #2: at 90℃; for 4 h; Inert atmosphere
A solution of 2,2-dimethyl-propane-l,3-diol (25.85 g, 248 mmol) in dioxane (400 mL) was cooled to 0°C. Potassium tert-butoxide (30 g, 267 mmol) was added portionwise to the cooled solution. The resulting mixture was stirred at room temperature for 1 h. (Bromomethyl)benzene (29.5 mL, 248 mmol) was added dropwise via addition funnel. The mixture was heated to 90°C and stirred for 4 h. The resulting mixture was concentrated in vacuo. The resulting residue was partitioned between water (200 mL) and ethyl acetate (200 mL) and extracted with ethyl acetate (3x200 mL). The organics were combined, washed with brine (100 mL), dried on sodium sulfate, and concentrated in vacuo. The crude material was purified by column chromatography (Si02, 5percent to 60percent ethyl acetate in heptane) to afford 3-benzyloxy-2,2-dimethyl-propan-1-ol as a yellow oil (24.84 g, 51percent). 1H NMR (CDCl3) : 7.28 - 7.42 (m, 5H), 4.52 (s, 2H), 3.47 (s, 2H), 3.34 (s, 2H), 0.94 (s, 6H). MS calcd. for C12H18O2 [(M+H)+] 195.3, obsd. 195.
12.50 g
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5 h;
Stage #2: at 20℃; for 16 h;
Sodium hydride (2.50 g, 105.62 mmol, 60percent in mineral oil) was suspended in dry DMF (150 ml) at 0° C. and a solution of 2,2-dimethylpropane-1,3-diol (10.0 g, 96.02 mmol) in DMF (50.0 ml) was added dropwise.
The RM was stirred at 0° C. for 30 min.
To the RM was added dropwise benzyl bromide (11.50 ml, 96.02 mmol) and the RM was allowed to warm to RT and stirred for 16 h.
The RM was diluted with water (300 ml) and the organic product was extracted with EtOAc (3*200 ml).
The organic layer was washed with brine (2*200 ml), dried over Na2SO4, filtered and the solvent evaporated in vacuo to give the crude product, which was purified by column chromatography (silica gel 60-120 mesh, 0-10percent EtOAc in PE) to get the title compound (12.50 g).

Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 13, p. 1466 - 1468
[2] Tetrahedron, 1986, vol. 42, # 21, p. 5941 - 5948
[3] Journal of the American Chemical Society, 2013, vol. 135, # 14, p. 5467 - 5474
[4] Patent: US2017/15675, 2017, A1, . Location in patent: Paragraph 1274
[5] Journal of Heterocyclic Chemistry, 2018, vol. 55, # 8, p. 1986 - 1990
[6] Chemistry - A European Journal, 2012, vol. 18, # 52, p. 16823 - 16827
[7] Patent: WO2016/44626, 2016, A1, . Location in patent: Paragraph 00435
[8] Angewandte Chemie - International Edition, 2000, vol. 39, # 1, p. 209 - 213
[9] Tetrahedron, 2016, vol. 72, # 2, p. 318 - 327
[10] Patent: US2009/82464, 2009, A1, . Location in patent: Page/Page column 45
[11] Patent: WO2014/153226, 2014, A1, . Location in patent: Paragraph 00319
[12] Patent: WO2015/42414, 2015, A1, . Location in patent: Paragraph 00509
[13] Patent: WO2013/189904, 2013, A1, . Location in patent: Page/Page column 47
[14] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 9, p. 1019 - 1024
[15] Journal of Organic Chemistry, 1985, vol. 50, # 15, p. 2707 - 2711
[16] Tetrahedron: Asymmetry, 1995, vol. 6, # 1, p. 271 - 282
[17] Patent: US2017/101397, 2017, A1, . Location in patent: Paragraph 0468; 0469
[18] Patent: WO2018/108231, 2018, A1, . Location in patent: Page/Page column 50
  • 2
  • [ 96556-40-0 ]
  • [ 66582-32-9 ]
YieldReaction ConditionsOperation in experiment
94% With lithium aluminium tetrahydride In tetrahydrofuran at -78 - 0℃; for 0.75 h; Inert atmosphere Methyl 3-(benzyloxy)-2,2-dimethylpropanoate (8a) (2.91 g, 13.1 mmol) was dissolved in THF and was cooled to -78 °C. LiAlH4 (14.4 mL, 14.4 mmol, 1 M) was added slowly via syringe to the solution. After stirring for 15 min at -78 °C, the cooling bath was removed and was replaced with an ice-water bath. The reaction mixture was stirred at 0 °C for 30 min. Excess LiAlH4 was quenched with ethyl acetate (3 mL). The mixture was warmed to r.t. and 0.55 mL water followed by 0.55 mL NaOH (15percent aq solution) followed by 1.65 mL water was added to the mixture and the resulting precipitate was removed by filtration through a pad of Celite with ethyl acetate rinsing. The filtrate was transferred to a separatory funnel containing saturated aqueous NaHCO3 solution (50 mL) and the aqueous layer was extracted with ethyl acetate (3 x 50 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered, and concentrated. The product was purified by column chromatography on silica gel (20percent → 25percent ethyl acetate in hexanes) to afford 3-(benzyloxy)-2,2-dimethylpropan-1-ol (8b) (2.40 g, 94percent yield) as a colorless oil: 1H NMR (400 MHz, CHLOROFORM-d) δ 7.39 - 7.25 (m, 5H), 4.50 (s, 2H), 3.45 (d, J=5.8 Hz, 2H), 3.31 (s, 2H), 0.92 (s, 6H); MS (ESI) m/e 195.2 [(M+H)+, calcd for C12H19O2 195.1].
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 6, p. 1360 - 1363
[2] Patent: US2012/322837, 2012, A1, . Location in patent: Page/Page column 98
  • 3
  • [ 776-88-5 ]
  • [ 66582-32-9 ]
Reference: [1] Chemistry Letters, 1995, # 3, p. 179 - 180
[2] Journal of Organic Chemistry, 1989, vol. 54, # 12, p. 2817 - 2825
[3] Tetrahedron Asymmetry, 2007, vol. 18, # 17, p. 2021 - 2029
[4] Journal of the Chinese Chemical Society, 2009, vol. 56, # 3, p. 510 - 523
[5] Synlett, 2004, # 4, p. 647 - 650
[6] Chemistry Letters, 1983, p. 1593 - 1596
[7] Organic Letters, 2011, vol. 13, # 5, p. 995 - 997
[8] Journal of the American Chemical Society, 2000, vol. 122, # 43, p. 10521 - 10532
  • 4
  • [ 100-44-7 ]
  • [ 126-30-7 ]
  • [ 66582-32-9 ]
Reference: [1] Tetrahedron Letters, 1997, vol. 38, # 8, p. 1359 - 1362
[2] European Journal of Organic Chemistry, 1999, # 11, p. 2817 - 2823
[3] Synlett, 2011, # 10, p. 1413 - 1418
[4] Tetrahedron Letters, 1977, p. 4257 - 4260
[5] Tetrahedron, 1988, vol. 44, # 13, p. 3899 - 3918
[6] Journal of pharmaceutical sciences, 1988, vol. 77, # 2, p. 149 - 152
  • 5
  • [ 116945-47-2 ]
  • [ 66582-32-9 ]
Reference: [1] Advanced Synthesis and Catalysis, 2013, vol. 355, # 11-12, p. 2151 - 2157
  • 6
  • [ 1125-88-8 ]
  • [ 66582-32-9 ]
Reference: [1] Tetrahedron Asymmetry, 2007, vol. 18, # 17, p. 2021 - 2029
[2] Organic Letters, 2011, vol. 13, # 5, p. 995 - 997
  • 7
  • [ 126-30-7 ]
  • [ 66582-32-9 ]
Reference: [1] Tetrahedron Letters, 1983, vol. 24, # 46, p. 5139 - 5140
[2] Journal of Organic Chemistry, 1989, vol. 54, # 12, p. 2817 - 2825
  • 8
  • [ 100-52-7 ]
  • [ 66582-32-9 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 12, p. 2817 - 2825
  • 9
  • [ 14002-80-3 ]
  • [ 66582-32-9 ]
Reference: [1] Patent: US2012/322837, 2012, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 6, p. 1360 - 1363
  • 10
  • [ 100-39-0 ]
  • [ 66582-32-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 6, p. 1360 - 1363
  • 11
  • [ 38216-93-2 ]
  • [ 66582-32-9 ]
Reference: [1] Chemistry - A European Journal, 2013, vol. 19, # 24, p. 7982 - 7988
Recommend Products
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 66582-32-9 ]

Aryls

Chemical Structure| 117087-18-0

[ 117087-18-0 ]

2-((Benzyloxy)methyl)propane-1,3-diol

Similarity: 0.97

Chemical Structure| 1003013-76-0

[ 1003013-76-0 ]

3-((Benzyloxy)methyl)oxetane

Similarity: 0.93

Chemical Structure| 4799-68-2

[ 4799-68-2 ]

3-(Benzyloxy)propan-1-ol

Similarity: 0.93

Chemical Structure| 14593-43-2

[ 14593-43-2 ]

((Allyloxy)methyl)benzene

Similarity: 0.90

Chemical Structure| 539-30-0

[ 539-30-0 ]

(Ethoxymethyl)benzene

Similarity: 0.90

Ethers

Chemical Structure| 117087-18-0

[ 117087-18-0 ]

2-((Benzyloxy)methyl)propane-1,3-diol

Similarity: 0.97

Chemical Structure| 1003013-76-0

[ 1003013-76-0 ]

3-((Benzyloxy)methyl)oxetane

Similarity: 0.93

Chemical Structure| 4799-68-2

[ 4799-68-2 ]

3-(Benzyloxy)propan-1-ol

Similarity: 0.93

Chemical Structure| 14593-43-2

[ 14593-43-2 ]

((Allyloxy)methyl)benzene

Similarity: 0.90

Chemical Structure| 539-30-0

[ 539-30-0 ]

(Ethoxymethyl)benzene

Similarity: 0.90

Alcohols

Chemical Structure| 117087-18-0

[ 117087-18-0 ]

2-((Benzyloxy)methyl)propane-1,3-diol

Similarity: 0.97

Chemical Structure| 4799-68-2

[ 4799-68-2 ]

3-(Benzyloxy)propan-1-ol

Similarity: 0.93

Chemical Structure| 868594-48-3

[ 868594-48-3 ]

1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol

Similarity: 0.87

Chemical Structure| 2050-25-1

[ 2050-25-1 ]

2-(2-(Benzyloxy)ethoxy)ethanol

Similarity: 0.87

Chemical Structure| 4541-14-4

[ 4541-14-4 ]

4-(Benzyloxy)butan-1-ol

Similarity: 0.87